MDXG logo

MiMedx (MDXG) Cash From Operations

Annual CFO

$26.77 M
+$44.67 M+249.64%

December 31, 2023

Summary

Performance

1-Year Change

+249.64%

3-Year Change

+188.47%

5-Year Change

-25.2%

15-Year Change

-57.46%

MDXG Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

83.41%
MDXG annual cash flow from operations is higher than 83.41% of companies in Healthcare sector

High & Low

All-time High

$62.94 M
MDXG annual cash flow from operations is currently -57.46% below its historical high of $62.94 million

3-Year Low

-$17.89 M

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
MDXG previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Feb 28, 2025
MDXG next annual earnings announcement is scheduled for Feb 28, 2025

OtherMDXGcash flowmetrics:

Annual CFI

-$2.15 M
MDXG annual cash flow from investing activities is -$2.15 million

Annual CFF

-$8.57 M
MDXG annual cash flow from financing activities is -$8.57 million

Annual FCF

$24.62 M
MDXG annual free cash flow is $24.62 million

Annual CAPEX

$1.99 M
MDXG annual capital expenditures is $1.99 million

Quarterly CFO

$19.62 M
-$2.19 M-10.04%

September 30, 2024

Summary

Performance

3-Month Change

-10.04%

1-Year Change

+228.27%

3-Year Change

+291.96%

5-Year Change

+184.87%

MDXG Quarterly CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

83.85%
MDXG quarterly cash flow from operations is higher than 83.85% of companies in Healthcare sector

High & Low

All-time High

$21.81 M
MDXG quarterly cash flow from operations is currently -10.04% below its historical high of $21.81 million

3-Year Low

-$10.22 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
MDXG previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Feb 28, 2025
MDXG next earnings announcement is scheduled for Feb 28, 2025

OtherMDXGcash flowmetrics:

Quarterly CFI

$113.00 K
MDXG quarterly cash flow from investing activities is $113.00 thousand

Quarterly CFF

$27.00 K
MDXG quarterly cash flow from financing activities is $27.00 thousand

Quarterly FCF

$19.45 M
MDXG quarterly free cash flow is $19.45 million

Quarterly CAPEX

$171.00 K
MDXG quarterly capital expenditures is $171.00 thousand

TTM CFO

$57.67 M
+$6.83 M+13.44%

September 30, 2024

Summary

Performance

3-Month Change

+13.44%

1-Year Change

+56.72%

3-Year Change

+1143.67%

5-Year Change

+246.33%

MDXG TTM CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

84.79%
MDXG TTM cash flow from operations is higher than 84.79% of companies in Healthcare sector

High & Low

All-time High

$69.68 M
MDXG TTM cash flow from operations is currently -17.23% below its historical high of $69.68 million

3-Year Low

-$17.89 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
MDXG previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Feb 28, 2025
MDXG next earnings announcement is scheduled for Feb 28, 2025

OtherMDXGcash flowmetrics:

TTM CFI

-$7.30 M
MDXG TTM cash flow from investing activities is -$7.30 million

TTM CFF

-$42.74 M
MDXG TTM cash flow from financing activities is -$42.74 million

TTM FCF

$50.46 M
MDXG TTM free cash flow is $50.46 million

TTM CAPEX

$7.21 M
MDXG TTM capital expenditures is $7.21 million

Cash From Operations Formula

CFO = Net Income + Non Cash Expenses + Changes In Working Capital

MDXG Cash From Operations Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+249.6%+228.3%+56.7%
3 y3 years+188.5%+292.0%+1143.7%
5 y5 years-25.2%+184.9%+246.3%

MDXG Cash From Operations Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+249.6%-10.0%+292.0%at high+422.3%
5 y5-yearat high+167.9%-10.0%+184.9%at high+233.8%
alltimeall time-57.5%+167.9%-10.0%+184.9%-17.2%+233.8%

MiMedx Cash From Operations History

DateAnnualQuarterlyTTM
Sep 2024
-
$19.62 M(-10.0%)
$57.67 M(+13.4%)
Jun 2024
-
$21.81 M(+264.9%)
$50.84 M(+38.1%)
Mar 2024
-
$5.98 M(-41.7%)
$36.80 M(+37.4%)
Dec 2023
$26.77 M(-249.6%)
$10.26 M(-19.8%)
$26.77 M(+145.8%)
Sep 2023
-
$12.79 M(+64.5%)
$10.89 M(-1261.4%)
Jun 2023
-
$7.78 M(-292.1%)
-$938.00 K(-92.0%)
Mar 2023
-
-$4.05 M(-28.0%)
-$11.72 M(-34.5%)
Dec 2022
-$17.89 M(+802.8%)
-$5.62 M(-686.4%)
-$17.89 M(+15.4%)
Sep 2022
-
$959.00 K(-131.9%)
-$15.50 M(+53.0%)
Jun 2022
-
-$3.00 M(-70.6%)
-$10.13 M(+83.3%)
Mar 2022
-
-$10.22 M(+216.3%)
-$5.53 M(+178.8%)
Dec 2021
-$1.98 M(-93.5%)
-$3.23 M(-151.1%)
-$1.98 M(-78.0%)
Sep 2021
-
$6.33 M(+295.9%)
-$9.02 M(-54.8%)
Jun 2021
-
$1.60 M(-123.9%)
-$19.96 M(-19.0%)
Mar 2021
-
-$6.68 M(-34.9%)
-$24.66 M(-18.5%)
Dec 2020
-$30.26 M(-23.2%)
-$10.27 M(+122.3%)
-$30.26 M(-29.8%)
Sep 2020
-
-$4.62 M(+49.1%)
-$43.12 M(+3.5%)
Jun 2020
-
-$3.10 M(-74.8%)
-$41.66 M(+14.3%)
Mar 2020
-
-$12.28 M(-46.9%)
-$36.43 M(-7.6%)
Dec 2019
-$39.41 M(-210.1%)
-$23.12 M(+631.7%)
-$39.41 M(+167.1%)
Sep 2019
-
-$3.16 M(-248.4%)
-$14.76 M(+80.0%)
Jun 2019
-
$2.13 M(-114.0%)
-$8.20 M(-179.1%)
Mar 2019
-
-$15.26 M(-1094.8%)
$10.36 M(-71.1%)
Dec 2018
$35.80 M(-43.1%)
$1.53 M(-54.8%)
$35.80 M(-35.1%)
Sep 2018
-
$3.40 M(-83.6%)
$55.13 M(-20.9%)
Jun 2018
-
$20.69 M(+103.3%)
$69.68 M(+11.5%)
Mar 2018
-
$10.18 M(-51.2%)
$62.48 M(-0.7%)
Dec 2017
$62.94 M(+163.9%)
$20.86 M(+16.2%)
$62.94 M(+10.9%)
Sep 2017
-
$17.95 M(+33.1%)
$56.77 M(+36.3%)
Jun 2017
-
$13.48 M(+26.7%)
$41.67 M(+17.5%)
Mar 2017
-
$10.64 M(-27.6%)
$35.47 M(+48.7%)
Dec 2016
$23.85 M(+26.8%)
$14.70 M(+416.7%)
$23.85 M(+76.6%)
Sep 2016
-
$2.85 M(-60.9%)
$13.50 M(-24.8%)
Jun 2016
-
$7.28 M(-845.1%)
$17.97 M(+31.9%)
Mar 2016
-
-$977.00 K(-122.4%)
$13.62 M(-27.6%)
Dec 2015
$18.81 M
$4.36 M(-40.4%)
$18.81 M(-17.3%)
DateAnnualQuarterlyTTM
Sep 2015
-
$7.31 M(+149.2%)
$22.74 M(-6.7%)
Jun 2015
-
$2.93 M(-30.3%)
$24.38 M(+7.7%)
Mar 2015
-
$4.21 M(-49.2%)
$22.62 M(+34.7%)
Dec 2014
$16.80 M(-6016.2%)
$8.29 M(-7.4%)
$16.80 M(+79.6%)
Sep 2014
-
$8.95 M(+658.3%)
$9.36 M(+337.7%)
Jun 2014
-
$1.18 M(-173.2%)
$2.14 M(+957.2%)
Mar 2014
-
-$1.61 M(-291.7%)
$202.20 K(-171.2%)
Dec 2013
-$284.00 K(-91.5%)
$840.70 K(-51.4%)
-$284.00 K(-85.8%)
Sep 2013
-
$1.73 M(-328.9%)
-$2.00 M(-56.5%)
Jun 2013
-
-$755.40 K(-64.0%)
-$4.59 M(+10.7%)
Mar 2013
-
-$2.10 M(+140.9%)
-$4.14 M(+24.3%)
Dec 2012
-$3.33 M(-50.0%)
-$870.90 K(+1.0%)
-$3.33 M(-19.1%)
Sep 2012
-
-$862.30 K(+177.4%)
-$4.12 M(-5.2%)
Jun 2012
-
-$310.90 K(-75.9%)
-$4.34 M(-29.5%)
Mar 2012
-
-$1.29 M(-22.2%)
-$6.16 M(-7.5%)
Dec 2011
-$6.66 M(-18.3%)
-$1.66 M(+52.0%)
-$6.66 M(-4.7%)
Sep 2011
-
-$1.09 M(-48.8%)
-$7.00 M(-14.4%)
Jun 2011
-
-$2.13 M(+19.0%)
-$8.18 M(+1.6%)
Mar 2011
-
-$1.79 M(-9.9%)
-$8.05 M(-1.3%)
Dec 2010
-$8.16 M(+45.8%)
-$1.99 M(-12.5%)
-$8.16 M(+32.2%)
Sep 2010
-
-$2.27 M(+13.4%)
-$6.17 M(+6.2%)
Jun 2010
-
-$2.00 M(+5.6%)
-$5.81 M(+4.6%)
Mar 2010
-
-$1.90 M(-0.6%)
-$5.56 M(-22.2%)
Dec 2009
-$5.60 M(-34.6%)
-
-
Sep 2009
-
-$1.91 M(+9.0%)
-$7.14 M(-6.8%)
Jun 2009
-
-$1.75 M(+31.3%)
-$7.66 M(-10.4%)
Mar 2009
-
-$1.33 M(-38.0%)
-$8.56 M(+18.4%)
Mar 2009
-$8.56 M(+5.2%)
-
-
Dec 2008
-
-$2.15 M(-11.7%)
-$7.22 M(+42.2%)
Sep 2008
-
-$2.43 M(-8.0%)
-$5.08 M(+90.9%)
Jun 2008
-
-$2.64 M(>+9900.0%)
-$2.66 M(>+9900.0%)
Mar 2008
-$8.14 M(>+9900.0%)
-
-
Dec 2007
-$23.70 K(+0.4%)
-$2800.00(-80.3%)
-$23.70 K(+13.4%)
Sep 2007
-
-$14.20 K(+576.2%)
-$20.90 K(+211.9%)
Jun 2007
-
-$2100.00(-54.3%)
-$6700.00(+45.7%)
Mar 2007
-
-$4600.00
-$4600.00
Dec 2006
-$23.60 K
-
-

FAQ

  • What is MiMedx annual cash flow from operations?
  • What is the all time high annual CFO for MiMedx?
  • What is MiMedx annual CFO year-on-year change?
  • What is MiMedx quarterly cash flow from operations?
  • What is the all time high quarterly CFO for MiMedx?
  • What is MiMedx quarterly CFO year-on-year change?
  • What is MiMedx TTM cash flow from operations?
  • What is the all time high TTM CFO for MiMedx?
  • What is MiMedx TTM CFO year-on-year change?

What is MiMedx annual cash flow from operations?

The current annual CFO of MDXG is $26.77 M

What is the all time high annual CFO for MiMedx?

MiMedx all-time high annual cash flow from operations is $62.94 M

What is MiMedx annual CFO year-on-year change?

Over the past year, MDXG annual cash flow from operations has changed by +$44.67 M (+249.64%)

What is MiMedx quarterly cash flow from operations?

The current quarterly CFO of MDXG is $19.62 M

What is the all time high quarterly CFO for MiMedx?

MiMedx all-time high quarterly cash flow from operations is $21.81 M

What is MiMedx quarterly CFO year-on-year change?

Over the past year, MDXG quarterly cash flow from operations has changed by +$13.65 M (+228.27%)

What is MiMedx TTM cash flow from operations?

The current TTM CFO of MDXG is $57.67 M

What is the all time high TTM CFO for MiMedx?

MiMedx all-time high TTM cash flow from operations is $69.68 M

What is MiMedx TTM CFO year-on-year change?

Over the past year, MDXG TTM cash flow from operations has changed by +$20.87 M (+56.72%)